Kodiak Sciences Inc (KOD)

Sep 26, 2026

Results are due Monday from a study of two potential treatments for an age-related eye disease. - Stock Titan

Sep 26, 2026

Sep 25, 2026

Kodiak Sciences to report phase 3 trial results Monday By Investing.com - Investing.com Canada

Sep 25, 2026

Sep 25, 2026

Stocks to Watch: Kodiak Sciences, Circle Internet Group - Moomoo

Sep 25, 2026

Sep 25, 2026

Kodiak Sciences to report phase 3 trial results Monday - Investing.com

Sep 25, 2026

Sep 25, 2026

Kodiak Sciences Inc. (KOD) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 25, 2026

Sep 25, 2026

Kodiak Sciences to reveal Phase 3 DAYBREAK stud... - pluang.com

Sep 25, 2026

Sep 25, 2026

Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration - Yahoo Finance

Sep 25, 2026

Sep 24, 2026

KOD Reinstated by Goldman Sachs -- Rating Set to Neutral - GuruFocus

Sep 24, 2026

Sep 24, 2026

Upcoming DAYBREAK Trial Results in Wet AMD Could Be A Game Changer For Kodiak Sciences (KOD) - Yahoo Finance

Sep 24, 2026

Sep 24, 2026

Goldman Sachs initiates Kodiak Sciences stock coverage with neutral rating - Investing.com

Sep 24, 2026

Sep 24, 2026

Goldman Sachs Reinstates Coverage on Kodiak Sciences (KOD) with Neutral Rating Amid Sector Resilience - GuruFocus

Sep 24, 2026

Sep 24, 2026

Kodiak Sciences (KOD) Stock Looks Overvalued After Its 15x Run - Yahoo Finance

Sep 24, 2026

Sep 23, 2026

The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte - Zacks Investment Research

Sep 23, 2026

Sep 23, 2026

Kodiak Sciences stock faces a clinical catalyst this fall - ad-hoc-news.de

Sep 23, 2026

Sep 22, 2026

4 Biotech Stocks With Key Clinical Readouts Expected This Fall - The Globe and Mail

Sep 22, 2026

Sep 17, 2026

H.C. Wainwright reiterates Kodiak Sciences stock rating on trial outlook By Investing.com - Investing.com Nigeria

Sep 17, 2026

Sep 17, 2026

H.C. Wainwright reiterates Kodiak Sciences stock rating on trial outlook - Investing.com

Sep 17, 2026

Sep 16, 2026

Kodiak Sciences: DAYBREAK Needs To Deliver More Than A Passing Grade (NASDAQ:KOD) - Seeking Alpha

Sep 16, 2026

Sep 13, 2026

3 Small-Cap Biotechs With Binary Catalysts on the Calendar - MarketBeat

Sep 13, 2026

Sep 11, 2026

KOD News | KODIAK SCIENCES INC (NASDAQ:KOD) - ChartMill

Sep 11, 2026

Sep 03, 2026

Kodiak Sciences (KOD) Races Toward Three Make-Or-Break Trial Verdicts - Yahoo Finance

Sep 03, 2026

Sep 01, 2026

Kodiak Sciences (KOD): Three Phase 3 Readouts In SightWill The Data See It Through? - RTTNews

Sep 01, 2026

Aug 27, 2026

Kodiak Sciences Inc (KOD) Peer Comparison – Compare with Others - valueresearchonline.com

Aug 27, 2026

Aug 26, 2026

What Kodiak Sciences (KOD)'s Widening Net Losses and Lower H1 Loss Per Share Mean For Shareholders - simplywall.st

Aug 26, 2026

Aug 21, 2026

Kodiak Sciences (NASDAQ:KOD) Stock Price Down 4.1%Time to Sell? - MarketBeat

Aug 21, 2026

Aug 20, 2026

Kodiak Sciences enrolls first patients in phase 3 DME trial By Investing.com - Investing.com Nigeria

Aug 20, 2026

Aug 19, 2026

HC Wainwright Lowers Earnings Estimates for Kodiak Sciences - MarketBeat

Aug 19, 2026

Aug 18, 2026

GSA Capital Partners LLP Takes $1.07 Million Position in Kodiak Sciences Inc. $KOD - MarketBeat

Aug 18, 2026

Aug 17, 2026

KOD Reiterates by HC Wainwright & Co. -- Price Target Maintained at $58 - GuruFocus

Aug 17, 2026

Aug 17, 2026

H.C. Wainwright reiterates Kodiak Sciences stock rating at buy By Investing.com - Investing.com Nigeria

Aug 17, 2026

Aug 17, 2026

HC Wainwright Reaffirms "Buy" Rating for Kodiak Sciences (NASDAQ:KOD) - MarketBeat

Aug 17, 2026

Aug 17, 2026

H.C. Wainwright reiterates Kodiak Sciences stock rating at buy - Investing.com

Aug 17, 2026

Aug 17, 2026

H.C. Wainwright Maintains Kodiak Sciences(KOD.US) With Buy Rating, Maintains Target Price $58 - Moomoo

Aug 17, 2026

Aug 16, 2026

Kodiak Sciences (KOD) Advances Late-Stage Trials Amid High Valua - GuruFocus

Aug 16, 2026

Aug 15, 2026

California State Teachers Retirement System Has $1.12 Million Stock Holdings in Kodiak Sciences Inc. $KOD - MarketBeat

Aug 15, 2026

Aug 15, 2026

Wall Street Zen Downgrades Kodiak Sciences (NASDAQ:KOD) to Sell - MarketBeat

Aug 15, 2026

Aug 14, 2026

UBS Maintains Kodiak Sciences(KOD.US) With Buy Rating, Maintains Target Price $80 - Moomoo

Aug 14, 2026

Aug 14, 2026

Kodiak Sciences (NASDAQ:KOD) Shares Gap DownTime to Sell? - MarketBeat

Aug 14, 2026

Aug 14, 2026

Kodiak's Q2 Loss Wider Than Expected, Pipeline Development in Focus - The Globe and Mail

Aug 14, 2026

Aug 13, 2026

Kodiak Sciences misses Q2 estimates, shares fall 5% By Investing.com - Investing.com Nigeria

Aug 13, 2026

Aug 13, 2026

Kodiak Sciences (NASDAQ:KOD) Releases Earnings Results, Misses Estimates By $0.09 EPS - MarketBeat

Aug 13, 2026

Aug 13, 2026

Kodiak Sciences misses Q2 estimates, shares fall 5% - Investing.com

Aug 13, 2026

Aug 13, 2026

Kodiak Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 13, 2026

Aug 13, 2026

Kodiak Sciences Q2 net loss widens on higher R&D costs - TradingView

Aug 13, 2026

Aug 13, 2026

Kodiak Sciences posts Q2 2026 net loss of $65.6M, cash $125.9M; DAYBREAK, PEAK readouts due Sept–Dec 2026 - TradingView

Aug 13, 2026

Aug 13, 2026

BRIEF-Kodiak Sciences Q2 Net Income USD -65.643 Million - TradingView

Aug 13, 2026

Aug 13, 2026

Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results - Yahoo Finance

Aug 13, 2026

Aug 12, 2026

Kodiak Sciences Enrols First Patients in Phase III ALTO Trial of KSI-501 for Diabetic Macular Edema - BioPharma APAC

Aug 12, 2026

Aug 12, 2026

Kodiak Sciences Inc. (KOD) stock price, news, quote and history - Yahoo Finance UK

Aug 12, 2026